Empowering mental health professionals with peer-reviewed psychiatric research and insights
Page 34
More JCP Articles
Original Research
Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in MDD
May 30, 2022
Altered glutamatergic neurotransmission has been implicated in the pathogenesis of depression. This phase 3 trial evaluated the efficacy and safety of AXS-05 (dextromethorphan-bupropion) in the treatment of major depressive…
Clinical and Practical Psychopharmacology
ADHD, ASD, and Other Neurodevelopmental Outcomes Associated With Antipsychotic Exposure During Pregnancy
May 30, 2022
Dr Andrade discusses the implications of 2 recent large cohort studies examining risk of neurodevelopmental disorders after gestational exposure to antidepressants.
Clinical and Practical Psychopharmacology
Antidepressant Drugs and Health-Related QoL: A Guide to Examining a “Viral” Research Paper
May 25, 2022
A recent study reporting no improvement in health-related quality of life with antidepressants went “viral” in the mass media. Here, Dr Andrade considers the shortcomings of the study and…
Insights
Measurement-Based Care for Depressive Disorders: Meta-Analysis of RCTs Shows Efficacy
May 17, 2022
Dr Lam explains in this video how for patients with depressive disorders treated with pharmacotherapy, measurement-based care is effective in decreasing symptom severity, promoting remission, and improving medication adherence.
